Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Deficiency Disorder

Explore clinical trials studying Primary Immune Deficiency Disorder. Study availability and eligibility vary by location and protocol.

21 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Deficiency Disorder trial results

Completed

Study of Octanorm Subcutaneous IG in Patients With PID

NCT01888484

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Birmingham, Alabama, United States
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site San Diego, California, United States
  • Octapharma Research Site Centennial, Colorado, United States
View all 24 locations
View Trial Details
Completed

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

NCT03988426

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • The State Research Center, Institute of Immunology of the Federal Medical-Biological Agency Moscow, Russia
  • Federal Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Health and Social Development of the Russian Federation Moscow, Russia
  • State Medical University Rostov-on-Don, Russia
  • Pasteur Institute Saint Petersburg, Russia
View Trial Details
Completed

Primary Immunodeficiency in Kuwait

NCT03618147

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Pediatric Deprtmemt, Alsabah hospital Kuwait City, Kuwait
View Trial Details
Completed

Octagam 5% Versus Comparator Post Marketing Trial

NCT01859754

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Granada Hills, California, United States
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site Los Angeles, California, United States
  • Octapharma Research Site Redlands, California, United States
View all 27 locations
View Trial Details
Completed

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

NCT01814800

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • IMMUNOe Health Centers Cenntennial, Colorado, United States
  • Allergy Associates of the Palm Beaches, P.A. North Palm Beach, Florida, United States
  • Family Allergy Center, PC Atlanta, Georgia, United States
  • The South Bend Clinic, LLP South Bend, Indiana, United States
View Trial Details
Completed

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

NCT01458171

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Fukuoka, Japan
  • Study site Gifu, Gifu Pref., Japan
View Trial Details

Related conditions